The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Open accessAbstract
Objectives: Existing treatments for schizophrenia can improve positive symptoms, but it is unclear if they have any impact on negative symptoms. This meta-analysis was conducted to assess the efficacy of available treatments for negative symptoms in schizophrenia. Methods: All randomized-controlled trials of interventions for negative symptoms in schizophrenia until December 2013 were retrieved; 168 unique and independent placebo-controlled trials were used. Negative symptom scores at baseline and follow-up, duration of illness, doses of medication, type of interventions, and sample demographics were extracted. Heterogeneity was addressed with the I2 and Q statistic. Standardized mean difference in values of the Negative Symptom Rating Scale used in each study was calculated as the main outcome measure. Results: 6503 patients in the treatment arm and 5815 patients in the placebo arm were included. No evidence of publication biases found. Most treatments reduced negative symptoms at follow-up relative to placebo: second-generation antipsychotics: −0.579 (−0.755 to −0.404); antidepressants: −0.349 (−0.551 to −0.146); combinations of pharmacological agents: −0.518 (−0.757 to −0.279); glutamatergic medications: −0.289 (−0.478 to −0.1); psychological interventions: −0.396 (−0.563 to −0.229). No significant effect was found for first-generation antipsychotics: −0.531 (−1.104 to 0.041) and brain stimulation: −0.228 (−0.775 to 0.319). Effects of most treatments were not clinically meaningful as measured on Clinical Global Impression Severity Scale. Conclusions and Relevance: Although some statistically significant effects on negative symptoms were evident, none reached the threshold for clinically significant improvement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cognitive behaviour therapy for schizophrenia
Jones, C., Cormac, I., Silveira da Mota Neto, J. I., & Campbell, C. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000524.pub2 · Cited by 269
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
(1976) · Medical Entomology and Zoology · Cited by 8,899
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
The Handbook of Research Synthesis and Meta-Analysis
(2019) · doi:10.7758/9781610448864 · Cited by 4,553
Scale for the Assessment of Negative Symptoms (SANS)*
(1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291502 · Cited by 2,701
Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
Leucht, S., Corves, C., Arbter, D., Engel, R. R., Li, C., & Davis, J. M. (2009) · The Lancet · doi:10.1016/s0140-6736(08)61764-x · Cited by 1,930
Scale for the Assessment of Negative Symptoms
Andreasen, N. C. (2014) · PsycTESTS Dataset · doi:10.1037/t12696-000 · Cited by 1,866
Deficit and nondeficit forms of schizophrenia: the concept
(1988) · American Journal of Psychiatry · doi:10.1176/ajp.145.5.578 · Cited by 1,332
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311
Self-citationA Meta-Analysis of Cognitive Remediation in Schizophrenia
McGurk, S. R., Twamley, E. W., Sitzer, D. I., McHugo, G. J., & Mueser, K. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07060906 · Cited by 1,214
Wykes, T., Steel, C., Everitt, B., & Tarrier, N. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm114 · Cited by 1,029
The Maudsley Prescribing Guidelines in Psychiatry
Taylor, D. M., Barnes, T. R. E., & Young, A. H. (2021) · Wiley eBooks · doi:10.1002/9781119870203 · Cited by 988
Leucht, S., Tardy, M., Komossa, K., Heres, S., Kissling, W., Salanti, G., & Davis, J. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60239-6 · Cited by 931
The Structure of Negative Symptoms Within Schizophrenia: Implications for Assessment
Blanchard, J. J., & Cohen, A. S. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj013 · Cited by 649
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Part III. Speculations on the Processes That Underlie Schizophrenic Symptoms and Signs
Strauss, J. S., Carpenter, W. T., & Bartko, J. J. (1974) · Schizophrenia Bulletin · doi:10.1093/schbul/1.11.61 · Cited by 574
Self-citationVentura, J., Hellemann, G. S., Thames, A. D., Koellner, V., & Nuechterlein, K. H. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.03.035 · Cited by 560
The Global Costs of Schizophrenia
Knapp, M., Mangalore, R., & Simon, J. (2004) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007078 · Cited by 536
Treatment of Negative Symptoms
Carpenter, W. T., Heinrichs, D. W., & Alphs, L. D. (1985) · Schizophrenia Bulletin · doi:10.1093/schbul/11.3.440 · Cited by 499
Self-citationSocial cognitive training for schizophrenia: a meta-analytic investigation of controlled research
Kurtz, M. M., & Richardson, C. L. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr036 · Cited by 446
Barnes, T. R., & the Schizophrenia Consensus Group of the British Association for Psychopharmacology (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110391123 · Cited by 356
Music therapy for people with schizophrenia and schizophrenia-like disorders
Geretsegger, M., Mössler, K. A., Bieleninik, Ł., Chen, X.-J., Heldal, T. O., & Gold, C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004025.pub4 · Cited by 348
Schizophrenia: Scientific progress
Coffman, J. A. (1990) · Schizophrenia Research · doi:10.1016/0920-9964(90)90026-4 · Cited by 334
Huhn, M., Tardy, M., Spineli, L. M., Kissling, W., Förstl, H., Pitschel-Walz, G., Leucht, C., Samara, M., Dold, M., Davis, J. M., et al. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.112 · Cited by 333
Linking the PANSS, BPRS, and CGI: Clinical Implications
Leucht, S., Kane, J. M., Etschel, E., Kissling, W., Hamann, J., & Engel, R. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301147 · Cited by 333
Rosenthal, R. (1991) · Psychosomatic Medicine · doi:10.1097/00006842-199105000-00001 · Cited by 315
Burden on the families of patients with schizophrenia: results of the BIOMED I study
Magliano, L., Fadden, G., Madianos, M., Caldas de Almeida, J. M., Held, T., Guarneri, M., Marasco, C., Tosini, P., & Maj, M. (1998) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050073 · Cited by 304
The Maudsley Prescribing Guidelines in Psychiatry (Full-Text Access)
(2025) · The Maudsley Prescribing Guidelines in Psychiatry · doi:10.1002/9781119870203.mpg016 · Cited by 290
Freitas, C., Fregni, F., & Pascual-Leone, A. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.11.027 · Cited by 251
Singh, S. P., Singh, V., Kar, N., & Chan, K. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.067710 · Cited by 223
Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review
Murphy, B. P., Chung, Y.-C., Park, T.-W., & McGorry, P. D. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.002 · Cited by 217
Leucht, S., Davis, J. M., Engel, R. R., Kane, J. M., & Wagenpfeil, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301325 · Cited by 216
Domains of psychopathology: an approach to the reduction of heterogeneity in schizophrenia.
Buchanan, R. W., & Carpenter, W. T. (1994) · PubMed · Cited by 210
Self-citationLectures on Clinical Psychiatry.
(1906) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1906.02510420061028 · Cited by 206
Lin, C.-H., Huang, C.-L., Chang, Y.-C., Chen, P.-W., Lin, C.-Y., Tsai, G. E., & Lane, H.-Y. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.009 · Cited by 203
Schizophrenia : scientific progress
Schulz, S. C., & Tamminga, C. A. (1989) · Oxford University Press eBooks · Cited by 200
Family burden and coping strategies in schizophrenia: 1-year follow-up data from the BIOMED I study
Fadden, G., Economou, M., Held, T., Xavier, M., Guarneri, M., Malangone, C., Marasco, C., Maj, M., & Magliano, L. (2000) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050192 · Cited by 194
Treatment of Schizophrenia Negative Symptoms: Future Prospects
Erhart, S. M., Marder, S. R., & Carpenter, W. T. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj055 · Cited by 185
Self-citationMusic therapy for people with schizophrenia and schizophrenia-like disorders
Mössler, K., Chen, X., Heldal, T. O., & Gold, C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004025.pub3 · Cited by 182
Leucht, S. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13049su1c.02 · Cited by 174
Domains of Psychopathology: An Approach to the Reduction of Heterogeneity in Schizophrenia
BUCHANAN, R. W., & CARPENTER, W. T. (1994) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199404000-00001 · Cited by 174
Self-citationManagement of the Negative Symptoms of Schizophrenia: New Treatment Options
M??ller, H.-J. (2003) · CNS Drugs · doi:10.2165/00023210-200317110-00003 · Cited by 141
de Lucena, D. F., Fernandes, B. S., Berk, M., Dodd, S., Medeiros, D. W., Pedrini, M., Kunz, M., Gomes, F. A., Giglio, L. M. F., Lobato, M. I. R., et al. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04935gry · Cited by 133
Villalta‐Gil, V., Vilaplana, M., Ochoa, S., Haro, J. M., Dolz, M., Usall, J., & Cervilla, J. A. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.06.013 · Cited by 100
Sarin, F., Wallin, L., & Widerlöv, B. (2011) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2011.577188 · Cited by 97
Cognitive rehabilitation for people with schizophrenia and related conditions
McGrath, J. J., & Hayes, R. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000968 · Cited by 96
Rummel, C., Kissling, W., & Leucht, S. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.07.035 · Cited by 82
A Review of Repetitive Transcranial Magnetic Stimulation Use in the Treatment of Schizophrenia
Fitzgerald, P. B., & Daskalakis, Z. J. (2008) · The Canadian Journal of Psychiatry · doi:10.1177/070674370805300903 · Cited by 57
Velligan, D. I., Alphs, L. D., Lancaster, S., Morlock, R., & Mintz, J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.009 · Cited by 57
Negative symptoms: diagnosis, treatment and prognosis
Buchanan, R. W., & Gold, J. M. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199605002-00002 · Cited by 56
A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation
Lepping, P., Schönfeldt‐Lecuona, C., Sambhi, R. S., Lanka, S. V., Lane, S., Whittington, R., Leucht, S., & Poole, R. (2014) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12276 · Cited by 51
New drugs for the treatment of schizophrenic patients
Fleischhacker, W. W. (1995) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1995.tb05941.x · Cited by 42
Domains of psychopathology relevant to the study of etiology and treatment in schizophrenia
Carpenter, W. T. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90064-3 · Cited by 34
Self-citationNonparametric trim and fill analysis of publication bias in meta-analysis: erratum
Steichen, T. J. (2001) · Stata technical bulletin · Cited by 32
Darbà, J., Minoves, A., Rojo, E., Jiménez, F., & Rejas, J. (2011) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/j.rpsmen.2011.02.001 · Cited by 15
Darbà, J., Minoves, A., Rojo, E., Jiménez, F., & Rejas, J. (2011) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2011.02.005 · Cited by 10
Cited by
Correll, C. U., & Schooler, N. R. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s225643 · Cited by 911
McGuire, P., Robson, P., Cubala, W. J., Vasile, D., Morrison, P. D., Barron, R., Taylor, A., & Wright, S. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17030325 · Cited by 617
Self-citationBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Improving outcomes of first‐episode psychosis: an overview
Fusar‐Poli, P., McGorry, P. D., & Kane, J. M. (2017) · World Psychiatry · doi:10.1002/wps.20446 · Cited by 575
Self-citationNegative symptoms of schizophrenia: new developments and unanswered research questions
Galderisi, S., Mucci, A., Buchanan, R. W., & Arango, C. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30050-6 · Cited by 555
Metadata
- Authors
- Fusar-Poli, P., Papanastasiou, E., Stahl, D., Rocchetti, M., Carpenter, W., Shergill, S., & McGuire, P.
- Venue
- Schizophrenia Bulletin
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-12-20
- Volume
- 41
- Issue
- 4
- Pages
- 892-899
- ISSN
- 0586-7614 (ISSN-L)
- 1745-1701
- OpenAlex
- W2104255009
- Cited by
- 683
- References
- 63
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.